• Mashup Score: 0

    Faculty AffiliationJohn M. Kane, MDThe Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York Financial DisclosureThe faculty for this CME activity and the CME Institute staff were asked to complete a statement regarding all relevant personal and financial relationships between themselves or their spouse/partner and any commercial interest. The Accreditation…

    Tweet Tweets with this article
    • Patients with #Schizophrenia may be willing to accept some adverse effects more than others. By reducing the conflicting side effect burden you may improve medication adherence. https://t.co/A50HhxM1NL @CMEInstitute | #PsychTwitter #CME #MedEd https://t.co/vK89emopC7

  • Mashup Score: 1

    Faculty AffiliationRobert S. Brown, Jr, MD, MPHWeill Cornell MedicineCenter for Liver DiseaseNew York, NYFinancial DisclosureThe CME Institute adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME). Any individuals in a position to control the content of a continuing education activity,…

    Tweet Tweets with this article
    • 👁️ ICYMI! 👁️ Improve your diagnostic acumen for #WilsonDisease and ability to parse its myriad manifestations. @drbobbybrown shares an update on the future of WD. https://t.co/fP02qYc5AW @CMEInstitute | #RareDiseases #NeuroTwitter #MedEd #CME https://t.co/BOhjDILbYh

  • Mashup Score: 0

    Support StatementSupported by an educational grant from Biogen.Learning ObjectiveAfter completing this educational activity, you should be able to:Discuss treatment goals and challenges with patients who have early-stage Alzheimer disease and their care partnersRelease, Review, and Expiration DatesThis brief report activity was published in April 2021 and is eligible for AMA PRA Category 1…

    Tweet Tweets with this article
    • If you treat early-stage #Alzheimer, you need to have these important conversations with your patients and their caregivers around diet, exercise, driving, and planning ahead for later stages. https://t.co/PD1bkAYQTj @CMEInstitute | # #NeuroTwitter #MedEd #CME https://t.co/Q0ikJy7qnU

  • Mashup Score: 0

    Faculty AffiliationMartha Sajatovic MDUniversity Hospitals Cleveland Medical CenterCleveland, OHJoseph McEvoy MDMedical College of GeorgiaAugusta, GA Faculty DisclosureThe CME Institute adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME). Any individuals in a position to control the…

    Tweet Tweets with this article
    • 🆕 Review the subtle symptoms of #Tardive dyskinesia and the huge impact early recognition and intervention can make for the patient's QOL. 🎥 Watch & Learn: https://t.co/yKMk6mIswR https://t.co/hGtKh6USsu

  • Mashup Score: 1

    Support StatementSupported by an educational grant from Eisai Inc.Learning ObjectiveAfter completing this educational activity, you should be able to:Provide evidence-based treatment for insomnia in older peopleRelease, Review, and Expiration DatesThis brief report activity was published in June 2021 and is eligible for AMA PRA Category 1 Credit™ through June 30, 2023. The latest review of this…

    Tweet Tweets with this article
    • Overcome challenges in managing #Insomnia for older patients. This brief review offers evidence-based treatment options that emphasize tolerability. https://t.co/NUB5RkfY09 @CMEInstitute | #SleepHealth #MedTwitter #MedEd https://t.co/YsSZm6XUXY

  • Mashup Score: 1

    Support StatementSupported by an educational grant from Intra-Cellular Therapies, Inc.Learning ObjectiveAfter completing this educational activity, you should be able to:Adopt a patient-centered approach to treatment for patients with schizophreniaRelease, Review, and Expiration DatesThis brief report activity was published in March 2021 and is eligible for AMA PRA Category 1 Credit™ through…

    Tweet Tweets with this article
    • Consider the value a patient-centered treatment approach for patients living with #Schizophrenia, which can include simplifying the medication regimen, using #SharedDecisionMaking, and psychosocial interventions. https://t.co/xiVVKmNqHO @CMEInstitute | #CME #MedEd #PsychTwitter https://t.co/9mRIEH7nvA

  • Mashup Score: 1

    Faculty Joseph F. Goldberg, M.D.Clinical Professor of PsychiatryIcahn School of Medicine at Mount SinaiNew York, NYHolly A. Swartz, M.D.Professor of PsychiatryUniversity of Pittsburgh School of MedicinePittsburgh, PA Melissa P. DelBello, MD, MSProfessor of Psychiatry and PediatricsDr. Stanley and Mickey Kaplan Professor and ChairDepartment of Psychiatry and Behavioral NeuroscienceUniversity of…

    Tweet Tweets with this article
    • Involving patients w/ #Bipolar in the design of their own treatment strategies per their own tolerability can help combat the 90% nonadherence rate. Click to learn more! https://t.co/KPNIXg4haT @CMEInstitute | #Psychiatry #CME #MedEdMonday https://t.co/r4DvvgN3f1

  • Mashup Score: 0

    Faculty AffiliationPhilip D. Harvey, PhDUniversity of Miami Miller School of Medicine, FloridaJohn M. Kane, MDZucker School of Medicine at Hofstra/Northwell, Hempstead, New YorkFinancial DisclosureThe faculty for this CME activity and the CME Institute staff were asked to complete a statement regarding all relevant personal and financial relationships between themselves or their spouse/partner…

    Tweet Tweets with this article
    • Overcome the most challenging adherence issues you face for patients living with #Schizophrenia. Click to learn more about this patient-centered approach. https://t.co/E1GnDkBaXW @CMEInstitute | #Psychiatry #CME #MedEd https://t.co/xIfzXjeK5P

  • Mashup Score: 1

    Support StatementSupported by an educational grant from Biogen.Learning ObjectiveAfter completing this educational activity, you should be able to:Consider how emerging agents focused on reducing progression would resolve unmet treatment needs in patients living with early-stage Alzheimer diseaseRelease, Review, and Expiration DatesThis brief report activity was published in May 2021 and is…

    Tweet Tweets with this article
    • For patients living with early-stage #Alzheimer disease, these emerging agents focus on reducing progression and could resolve unmet treatment needs. Click to learn the latest! https://t.co/PsA1KWqIcd @CMEInstitute | #CME #MedEd #NeuroTwitter https://t.co/IIqmS3zMoE

  • Mashup Score: 1

    Support StatementSupported by an educational grant from ACADIA Pharmaceuticals Inc.Learning ObjectiveAfter completing this educational activity, you should be able to:Initiate evidence-based therapies to manage psychosis in patients with dementia as soon as symptoms are identifiedMonitor treatment of psychosis in patients with dementiaRelease, Review, and Expiration DatesThis brief report…

    Tweet Tweets with this article
    • Antipsychotics can be used in the short-term to manage #Dementia-related psychosis, but serious AEs can outweigh benefits. Consider this alternative for superior efficacy and safety. https://t.co/2OwpQHvv0q 🎤 @Clive_Ballard | #NeuroTwitter #PsychTwitter https://t.co/ccTTClVo4E